NLM

1. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Vol. 8,
Human Vaccines and Immunotherapeutics. 2012. P. 81-8.

2. Beigel JH. Influenza. Crit Care Med [Internet]. 2008;36(9):2660-6. Available from:
http://www.content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=000
03246-200809000-00025

3. CDC, Influenza type A Viruses | Avian Influenza (Flu) [Internet]. Centers for Disease
Control and Prevention. 2015. Available from:
http://www.cdc.gov/flu/avianflu/influenza-a-virus-subtypes.htm

4. Kilbourne ED. Influenza pandemics of the 20th century. Vol. 12, Emerging Infectious
Diseases. 2006. P. 9-14.

5. Medlock J, Galvani AP. Optimizing Influenza Vaccine Distribution. Science (80-)

[Internet]. 2009;325(5948):1705-8. Available from:
http://www.sciencemag.org/cgi/doi/10.1126/science.1175570

6. Mills CE, Robins JM, Lipstich M. Transmissbility of 1918 pandemic influenza. Nature
[Interner]. 2004;432(7019):904-6. Available from:
http://www.nature.com/dofinder/10.1038/nature03063

7. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin

H1N1 influenza virus. Nature [Internet]. 2009;459(7249):931-9. Available from:
http://www.nature.com/doifender/10.1038/nature08157

8. Tao YJ, Zheng W, Visualizing the Influenza Genome. Science (80-) [Internet].
2012;338(6114):1545-6. Available from:
http://www.sciencemag.org/cgi/doi/10.1126/science.1231588

9. World Health Organization. Influenza (Seasonal): fact sheet [Internet]. World Health
Organization. 2014. p. 1-4. Available from:
http://www.who.int/mediacentre/factsheets/fs211/en/

10. Zhang X, Friedl MA, Schaaf CB. Avian Influenza [Internet]. Vol. 111, Journal of
Geophysical Research. 2006. 48-86 p. Available from:
http://www.influenzareport.com/influenzareport.pdf
APA

Amborse, C. S., & Levin, M.J. (2012). The rationale for quadrivalent influenza vaccines.
Human vaccines and immunotherapeutics. http://doi.org/10.4161/hv.8.1.17623

Beigel, J. H. (2008). Influenza. Critical Care Medicine, 36(9), 2660-2666.

http://doi.org/10.1097/CCM.0b013e318180b039

CDC, (2015). Influenza type A Viruses | Avian Influenza (Flu). Retrived from
http://www.cdc.gov/flu/avianflu/influenza-a-virus-subtypes.htm

Kilbourne E. D. (2006) Influenza pandemics of the 20th century. Emerging Infectious

Diseases. http://doi.org/10.3201/eid1201.051254

Medlock J,. & Galvani AP. (2009). Optimizing Influenza Vaccine Distribution. Science,
325(5948),1705-1708. http://doi.org/10.1126/science.1175570

Mills CE, Robins J.M, & Lipstich M. (2004) Transmissbility of 1918 pandemic influenza.
Nature, 432(7019), 904-906. http://doi.org/10.1038/nature03063

Neumann G, Noda T,. & Kawaoka Y. (2009) Emergence and pandemic potential of swine-
origin H1N1 influenza virus. Nature, 459(7249), 931-939.
http://doi.org/10.1038/nature08157

Tao Y. J., & Zheng W, (2012) Visualizing the Influenza Genome. Science, 338(6114), 1545-
1546, http://doi.org/10.1126/science.1231588

World Health Organization. (2004) Influenza (Seasonal): fact sheet. https://doi.org/D

Zhang X, Friedl M. A., & Schaaf , C. B. (2006) Avian Influenza. Journal of Geophysical
Research (Vol.111). http://doi.org/10.1017/CB09781107415324.004
AMA

1. Halstead SB. Dengue. Curr Opin Infect Dis. 2002:15(5):471-476. Doi:10.1016/S0140-

6736(07)61687-0.

2. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue
antibodies are important in the development of dengue hemoraghic fever in infants. Am J
Trop Med Hyg. 1988;38(2):411-419.doi:10.4269/AJTMH. 1988.38.411.

3. Krishnapradeep S, kekulawala KRCP, An uncommon case of dengue shock syndrome.

Sri Lanka Journal of child heal. 2012;41(1):42-43. Doi:10.4038/sljch.v4lil.4137.

4. Morens DM, Sather GE, Gubler DJ, Rammohan M, Woodall JP. Dengue shock
syndrome in a American traveler with primary dengue 3 infection. Am J Trop Med Hyg.
1987;36(2):424-426.

5. Rajapakse S. Dengue shock. J Emerg Trauma Shock. 2011;4(1):120. Doi.10.4103/0974-

2700.76835.

6. Rigau-Prez JG, Clark GG, Gubler DJ, Reiter P, Sander EJ, Vance Vorndam A. Dengue
and dengue haemorraghic faver. Lancet. 1988;352(9132):971-977. Doi:10.1016/S0140-
6736(97)12483-7.

7. Rodenhuis-Zybert IA, wilschut J, Smith JM. Dengue virus life cycle: Viral and host
factors modulating infectivity. Cell Mol Life Sci. 2010;67(16):2773-2786. Doi:
10.1007/s00018-010-0357-z.

8. Scott RM, Nimmannitya S, Bancorft WH, Mansuwan P. Shock syndrome in primary

dengue infections. Am J Trop Med Hyg. 1976;25(6):866-874

9. Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive
markers for dengue shock syndrome. J Trop Pediatr. 2004;50(5):301-305.
Doi:10.1093/tropej/50.5.30.

10. Wills BA, Oragui EE, Stephens AC, dt al. Coagulation Abnormalities in dengue
Hemorraghic fever. Serial Investigations in 167 Vietnamese children with Dengue Shock
Syndrom. Clinical Infect Dis. 2002;35(3):277-285.doi:10.1086/341410.